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Abstract
Background: Previous studies have suggested that the process of HIV-1 tRNA primer selection
and encapsidation of genomic RNA might be coupled with viral translation. In order to further
investigate this relationship, proviruses were constructed in which the primer-binding site (PBS)
was altered to be complementary to elongator tRNAMet (tRNAMet(e)) (HXB2-Met(e)) or initiator
tRNAMet (tRNAMet(i)) (HXB2-Met(i)). These tRNAMet not only differ with respect to the 3' terminal
18-nucleotides, but also with respect to interaction with host cell proteins during protein synthesis.
Results: Consistent with previous studies, HXB2-Met(e) were infectious and maintained this PBS
following short-term in vitro culture in SupT1 cells. In contrast, transfection of HBX2-Met(i)
produced reduced amounts of virus (as determined by p24) and did not establish a productive
infection in SupT1 cells. The low infectivity of the virus with the PBS complementary to tRNAMet(i)
was not due to differences in endogenous levels of cellular tRNAMet(i) compared to tRNAMet(e);
tRNAMet(i) was also capable of being selected as the primer for reverse transcription as determined
by the endogenous reverse transcription reaction. The PBS of HXB2-Met(i) contains an ATG,
which could act as an upstream AUG and syphon scanning ribosomes thereby reducing initiation
of translation at the authentic AUG of Gag. To investigate this possibility, a provirus with an A to
G change was constructed (HXB2-Met(i)AG). Transfection of HXB2-Met(i)AG resulted in
increased production of virus, similar to that for the wild type virus. In contrast to HXB2-Met(i),
HXB2-Met(i)AG was able to establish a productive infection in SupT1 cells. Analysis of the PBS
following replication revealed the virus favored the genome with the repaired PBS (A to G) even
though tRNAMet(i) was continuously selected as the primer for reverse transcription.
Conclusion: The results of these studies suggest that HIV-1 has access to both tRNAMet for
selection as the replication primer and supports a co-ordination between primer selection,
translation and encapsidation during virus replication.
Background
A distinguishing feature of retrovirus replication is the
process of reverse transcription in which the RNA genome
is converted to a DNA intermediate prior to integration
into the host cell chromosome. Reverse transcription is
carried out by a virally encoded enzyme, reverse tran-
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scriptase [1,2]. The initiation of reverse transcription
occurs at a site near the 5' end of the viral RNA genome
termed the primer-binding site (PBS) [3-5]. Initiation uses
a host cell tRNA primer which is selected from the intrac-
ellular milieu and positioned at the PBS. Different retrovi-
ruses select specific tRNAs [6,7]. For example, murine
leukemia virus selects tRNAPro, avian leukosis virus selects
tRNATrp while lentiviruses, including human immunode-
ficiency virus type 1 (HIV-1), select tRNALys,3 as the primer
for reverse transcription [8-11].
The mechanism of tRNA primer selection by retroviruses
is not completely understood. Studies with HIV-1 have
suggested that interactions between Gag and Gag-pol with
host aminoacyl synthetase could facilitate the selection of
tRNALys,3 [12-14]. However, alteration of the PBS to be
complementary to a number of different tRNAs allows
these primers to be selected for reverse transcription [15-
17]. Previous studies have shown that HIV-1 could stably
utilize tRNAHis, tRNAGlu, tRNAMet, or tRNALys1,2 if muta-
tions of the PBS were accompanied by mutations within
U5 to be complementary to the anticodon of the tRNA
[18-23]. Recently, mutation of an additional region in U5,
the primer activation site (PAS), to be complementary to
tRNALys1,2 has also been shown to allow continued selec-
tion of tRNALys1,2 [24]. However, not all tRNAs can be sta-
bly used by HIV-1 as primers, even with A-loop
modifications, suggesting that tRNA availability can influ-
ence preference for primer selection [22,23].
Any understanding of tRNA primer selection needs to take
into account the complex biosynthetic pathway of tRNAs
and host cell translation. Following transcription in the
nucleus, the tRNA interacts with a myriad of host cell pro-
teins that are involved in processing, aminoacylation and
transport from the nucleus to the cytoplasm [25]. The
results of our previous studies have suggested a coupling
between translation and selection of the tRNA primer
used for reverse transcription [26]. In these studies, we
found that tRNA transport from the nucleus to the cyto-
plasm was essential for selection and that aminoacylation
of the tRNA, while not absolutely required, greatly
enhanced the selection of the tRNA as a primer. Consist-
ent with the link between primer selection and translation
is that the synthesis of HIV-1 Gag is co-ordinated with
encapsidation of genomic RNA [27].
In previous studies, we have described the construction
and characterization of an HIV-1 in which the PBS was
made complementary to tRNAMet used in translation elon-
gation (tRNAMet(e)) [20,22]. Upon extended culture of
HIV-1 in SupT1 cells, the PBS reverted to utilize tRNALys,3,
although we were able to stabilize the use of tRNAMet(e)
with additional mutations within U5. Two tRNAMet exist
in cells that are involved in either initiation (tRNAMet(i)) or
elongation (tRNAMet(e)) of translation [28,29]. The tRNAs
differ in eleven of the eighteen 3' terminal nucleotides
(Figure 1) [28,30] and interact with a different comple-
ment of host proteins that are involved in translational
initiation or elongation [29]. Thus, HIV-1 with a PBS com-
plementary to tRNAMet(i) or tRNAMet(e) would be expected
to have to access different pools of tRNAMet and interact
with different host cell proteins during primer selection.
In the current study, HIV-1 in which the PBS was made
complementary to tRNAMet(e) was shown to be replication
competent and utilize this tRNA during early stages of in
vitro culture prior to eventually reverting to utilize tRNA-
Lys,3. In contrast, viruses in which the PBS were made com-
plementary to tRNAMet(i), had reduced production of virus
and were not infectious following long-term culture with
SupT1 cells. Mutation of the AUG codon located in the
PBS complementary to tRNAMet(i) restored infectivity of
this virus but at levels lower than the wild type. Analysis
of the PBS following replication revealed a preference for
the PBS containing the mutated PBS (AUG to GUG). The
results of these studies are discussed with respect to the co-
ordination of HIV-1 primer selection, viral translation and
encapsidation of the genomic RNA.
Results
Construction of HIV-1 proviruses with PBS complementary 
to tRNAMet(e) or tRNAMet(i)
In previous studies, we have described the isolation and
characterization of a HIV-1 mutant in which the PBS was
complementary to tRNAMet(e) (HXB2-Met(e)) [20,22,31].
Subsequent characterization and re-derivation HXB2-
Met(e) revealed that this virus could select tRNAMet(e) fol-
lowing short-term in vitro culture before reverting to uti-
lize tRNALys,3. For the current study, we constructed a HIV-
1 proviral genome in which the PBS was made comple-
mentary to tRNAMet(i) [28,30,32]. The PBS of HXB2-Met(i)
differs by 11 nucleotides from the PBS of HXB2-Met(e)
(Figure 1).
Infectivity of HIV-1 with PBS complementary to tRNAMet(e) 
or tRNAMet(i)
To characterize the effects of the PBS mutations on HIV-1
replication, we first analyzed the production of infectious
virus following transfection of wild type and mutant pro-
viral genomes. 293T cells were transfected with equal
amounts of proviral DNA and the supernatants analyzed
for the production of infectious virus using the JC53-BL
assay [33]. The numbers of infectious units were calcu-
lated by determining the amount of cells expressing beta-
galactosidase following infection with culture
supernatants. Modification of the PBS to be complemen-
tary to tRNAMet(e) (HXB2-Met(e)) resulted in production
of infectious virus at approximately 20% level of the wild
type virus. The reduced production of infectious virus as a
result of alteration of the PBS has been found for virusesRetrovirology 2007, 4:10 http://www.retrovirology.com/content/4/1/10
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with different PBS [34,35]. In contrast, viruses with the
PBS complementary to tRNAMet(i)  (HXB2-Met(i)) pro-
duced even lower amounts of infectious virus, approxi-
mately 2% of the wild type virus (Figure 2A). To further
explore the nature of the low production of infectious
virus, we analyzed the culture supernatants for p24 anti-
gen. Previous studies from this laboratory have demon-
strated that viruses with alterations in the PBS produce
similar levels of p24 antigen as wild type virus [15,20,21].
Consistent with these results, we found that transfecting a
range of HXB2-Met(e) and HXB2-WT produced similar
levels of p24 antigen in culture supernatants. In contrast,
transfection HXB2-Met(i) yielded approximately 50% less
p24 antigen in comparison to HXB2-Met(e) and HXB2-
tRNA and HIV-1 proviruses Figure 1
tRNA and HIV-1 proviruses. Panel A. tRNAMet(e) and tRNAMet(i). HeLa cell tRNAMet(e) and tRNAMet(i). The nucleotides 
shown in large boldface type in the tRNA are complementary to the PBS of the viral RNA genome. Diagram of tRNAMet as 
described by Harada et al [49]. Panel B. Genomes with PBS complementary to tRNAMet(e) or tRNAMet(i). The 5' region of the 
HIV-1 RNA genome is expanded to depict the locations of sequences having complementarity with the 3' 18 nucleotides of the 
tRNA (bolded). The wild-type PBS (nucleotides 183 to 200) in HXB2 was replaced with the PBS complementary to the 3'-ter-
minal 18 nucleotides of tRNAMet(e) [HXB2-Met(e)] or tRNAMet(i) [HXB2-Met(i)].
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WT (Figure 2B). This reduced level of p24 antigen produc-
tion of HXB2-Met(i) was consistent over a range of plas-
mid concentrations used for transfection. Thus, the
alteration of the PBS to be complementary to tRNAMet(i)
reduces the production of both infectious virus and p24
antigen in the culture supernatant.
One explanation for the reduced p24 could be that there
is a disruption in the proteolytic processing of HIV-1,
resulting in the production of greater levels of processed
virions released from the cells. Since the p24 antigen
ELISA does not efficiently recognize unprocessed Gag
(pr55Gag) this would result in lower amounts of virus
detected from transfection of HXB2-Met(i). To address
this issue, pelleted virus particles from culture superna-
tants were analyzed by Western blot with polyclonal anti-
bodies against HIV-1 Gag (Figure 2C). HXB2-WT, HXB2-
Met(e) and HXB2-Met(i) had greater CA p24 antigen than
pr55Gag, indicating that proteolytic processing was proba-
bly not effected by the alteration of the PBS. Interestingly,
the Western blot revealed that the p24 antigen for HXB2-
WT and HXB2-Met(e) was approximately 3 to 5 times that
for pr55Gag, whereas the ratio of CA p24 to pr55Gag for
viruses derived from HXB2-Met(i) was considerably
greater, approximately 10 to 50 times. Using recombinant
pr55Gag  as a standard, we estimate that the levels of
pr55Gag in viruses derived from HXB2-Met(i) was approx-
imately 10 times less than that from viruses derived from
the HXB2-Met(e) or HXB2-WT (data not shown). Collec-
tively, the results of these studies demonstrate that altera-
tion of the PBS to be complementary to tRNAMet(i), in
contrast to viruses with a PBS complementary to
tRNAMet(e), resulted in reduced production of virus parti-
cles.
Replication of HIV-1 with PBS complementary to 
tRNAMet(e) or tRNAMet(i)
We next examined replication of viruses in which the PBS
was altered to be complementary to tRNAMet(i)  or
tRNAMet(e) in a continuous T cell line (SupT1). Although
previous studies in this laboratory have shown that
viruses with an altered PBS without mutations in the U5
region can utilize a variety of tRNA primers, a hallmark of
all of these studies is the fact that the virus reverts to utilize
tRNALys,3 following in vitro culture [15-17]. As expected,
wild type virus grew rapidly in these cultures resulting in
many giant cell syncytia typical for HXB2-WT infection of
SupT1 cells. Using the same amount of infectious virus,
HXB2-Met(e) initially grew slower than HXB2-WT but
eventually reached a level of p24 antigen in culture super-
natants similar to that of wild type virus (Figure 3). Anal-
ysis of the PBS from integrated proviruses revealed that
tRNAMet(e) was used as the primer for reverse transcription
at early times of the infection but upon extended growth,
the viruses reverted to utilize tRNALys,3 (data not shown).
In contrast, HXB2-Met(i) did not show detectable growth
following infection of SupT1 cells. The p24 antigen
amounts in culture supernatants did not increase over
time and visually we did not observe giant cell syncytia
indicative of a productive HIV-1 infection of SupT1 cells.
We repeated this infection with 10 times the amount of
p24 antigen, and again were unable to detect production
of infectious virus following culture with SupT1 with
HXB2-Met(i) (data not shown). In a third attempt, we
increased the amount of HXB2-Met(i) so that the total
amount of infectious virus was increased by 5 or 10 fold
over the initial experiment. The amount used was equiva-
lent to approximately 5 and 10 times the necessary infec-
tious units needed by HXB2-WT or HXB2-Met(e) to
initiate a productive infection. Even after extending the
culture time to over 200 days, there was no evidence of
infectious virus production as measured by p24 antigen
capture (data not shown).
One explanation for the low infectivity of viruses with the
PBS complementary to tRNAMet(i) is that the total amount
of tRNAMet(i)in cells is limiting relative to tRNAMet(e). To
address this issue, we compared the amounts of tRNAMet(i)
with tRNAMet(e) and tRNALys,3 found in SupT1 cells. We
first established that our probes were specific for the indi-
vidual tRNA species to be analyzed (data not shown).
Using known amounts of in vitro transcribed tRNAs, we
established a concentration curve to analyze the relative
levels of the designated tRNAs (Figure 4). Under our
experimental conditions, we found that the total amount
of tRNAMet(e) and tRNAMet(i) were comparable in SupT1
cells. The levels of tRNAMet(e) were approximately 50%
that for tRNALys,3. Similar amounts of tRNAMet(e)  and
tRNAMet(i) were found in 293T cells (data not shown).
The reduced infectivity of HXB2-Met(i) could be a result
of tRNAMet(i) not being selected from the intracellular
milieu as the primer for HIV-1 reverse transcription. To
address this issue, we analyzed the isolated viruses from
transfection for the capacity to undergo minus strong-stop
DNA synthesis (endogenous reaction). In this reaction,
the viruses use the tRNA primer complementary to the
PBS to initiate reverse transcription and synthesize minus
strong-stop DNA. Previous studies from our laboratory
have confirmed that the wild type virus uses tRNALys,3 and
the virus for HXB2-Met(e) uses tRNAMet(e) [20,21]. Viruses
were isolated from transfection supernatants by pelleting.
The products from endogenous reverse transcription reac-
tions were analyzed after different in vitro reaction times.
The amounts of radionucleotide incorporation were then
normalized to p24 levels (Figure 5). As the in vitro reaction
time increased, we observed a linear increase in radioac-
tivity from HXB2-WT. Similar observations were made for
HXB2-Met(e) and HXB2-Met(i) albeit the levels that were
approximately 70% those of the wild type virus. TheRetrovirology 2007, 4:10 http://www.retrovirology.com/content/4/1/10
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Characterization of recombinant viruses with PBS complementary to tRNAMet(e) and tRNAMet(i) Figure 2
Characterization of recombinant viruses with PBS complementary to tRNAMet(e) and tRNAMet(i). Panel A. Pro-
duction of infectious virus following transfection of proviral plasmids. The designated proviral plasmids were transfected into 
293T cells and the supernatant assayed for production of infectious virus using the JC53-BL assay. Culture volumes for each 
virus were the same. Error bars ± standard deviation. Panel B. p24 antigen production from transfected cells. Cells were 
transfected with different amounts of HXB2-WT, HXB2-Met(e) or HXB2-Met(i) and the p24 antigen in the culture superna-
tant was determined by solid phase ELISA. The amounts for each transfection was as follows: Lane 1 : 1 μg, Lane 2 : 2 μg, Lane 
3 : 3 μg, Lane 4 : 4 μg, Lane 5 : 8 μg of proviral plasmid DNA. Panel C. Analysis of virus produced from transfected cells. Virus 
from transfected cells was pelleted by ultracentrifugation and subjected to SDS PAGE and Western blot using antibody specific 
for HIV-1 Gag. The order of the samples are as follows: Lane 1 – HXB2-Met(e), Lane 2 : HXB2-Met(i), Lane 3 : HXB2-WT. 
The positions of a viral gag gene products CA p24, p41 and pr55Gag are noted.
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amount of incorporation observed for HXB2-Met(e) were
similar to those for HXB2-Met(i) when the values were
normalized for p24 antigen (i.e. amount of virus parti-
cles). Collectively, the results of these studies suggest that
both tRNAMet(e) and tRNAMet(i) were able to be selected as
the cognate tRNA as the primer for reverse transcription.
An AUG codon in the PBS of HXB2-Met(i) impacts 
production of virus
Finally, we noted that as a consequence of the alteration
of the PBS to be complementary to tRNAMet(i), a new AUG
sequence was present in the 5' NTR of the HIV-1 genome
(Figure 6). In theory, this AUG could act to syphon off
scanning ribosomes and reduce initiation of translation at
the AUG used for synthesis of Gag. To address this possi-
bility, we mutated the ATG to GTG in HXB2-Met(i) and
determined the effect on the production of virus following
transfection (Figure 6). The virus with A to G mutation
(HXB2-Met(i)AG) produced similar amounts of virus as
that from HXB2-WT or HXB2-Met(e) following transfec-
tion into 293T cells, consistent with the idea that elimina-
tion of the AUG restored the production of the virus.
Analysis of the amount of infectious virus produced as
measured by the JC53-BL assay revealed that lower
amounts were produced than the wild type virus, but were
now similar to that produced from transfection of HXB2-
Met(e).
We next examined the replication of HIV-1 with the PBS
complementary to tRNAMet(i) that contained the A to G
mutation in SupT1 cells. Consistent with our previous
result, HXB2-Met(i) did not demonstrate any significant
Replication of virus with PBS complementary to tRNAMet(e) or tRNAMet(i) Figure 3
Replication of virus with PBS complementary to tRNAMet(e) or tRNAMet(i). Plasmids containing wild type or mutant 
proviral genomes were transfected into 293T cells. The virus was collected 48 hours later and the amount of infectivity deter-
mined using the JC53 assay. SupT1 cells were then infected with equal amounts of wild type or mutant viruses. The supernatant 
p24 measured at different times post infection. By day 21 and later, we recovered virus in which the PBS from HXB2-Met(e) 
had mutated to be complementary to tRNALys,3. The culture for HXB2-Met(i) was extended to over 200 days with no subse-
quent rise in p24 antigen. Key: squares (HXB2-WT); closed circles (HXB2-Met(e)); open circles HXB2-Met(i).
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Comparison of intracellular levels of tRNAMet(e) or tRNAMet(i) Figure 4
Comparison of intracellular levels of tRNAMet(e) or tRNAMet(i). Panel A. Analysis of tRNAs from SupT1 cells. Increas-
ing amounts of in vitro transcribed tRNA and total RNA isolated from SupT1 cells were subjected to Northern blot analysis. 
Each sample set was probed with the corresponding polynucleotide [γ-32P] kinased oligo nucleotide. Shown is a picture of the 
audioradiogram from the probed samples. The amount of radioactivity in each spot was determined by excising the region and 
direct counting.Panel B. Comparison of the relative amounts of tRNAs from SupT1 cells. The amounts of tRNALys,3, 
tRNAMet(e) or tRNAMet(i) was determined from the quantitative analysis of the Northern blot presented in Panel A. When 
amount of tRNALys,3 was set at 100%, the levels of tRNAMet(e) and tRNAMet(i) were approximately equal and overall approxi-
mately 50% that of tRNALys,3.
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increase in p24 antigen in the culture period (up to 49
days post initiation of culture). In contrast, HXB2-
Met(i)AG had very low levels of replication up to Day 28,
at which time virus levels slowly increased in the culture.
Inspection of the cultures revealed the presence of syncy-
tia, also confirming virus replication.
We next wanted to determine the status of the PBS in
HXB2-Met(i)AG infected cultures. For these studies, we
utilized PCR to amplify the U5-PBS region from inte-
grated proviruses obtained at later times during culture
when the virus replication was evident. Analysis of the
U5-PBS from two different time points (Day 35 and Day
49) revealed presence of PBS complementary to tRNAMet(i)
or PBS complementary to tRNAMet(i) with the A to G muta-
tion (tRNAMet(i)AG). In an earlier time point examined, we
recovered approximately 50% of the TA clones from the
PCR reaction were complementary to the tRNAMet(i) or
tRNAMet(i)AG. At the later time point, though, nearly all of
the TA clones recovered (8 of 9) were complementary to
the PBS with the A to G mutation (data not shown). Thus,
HXB2-Met(i)AG had maintained the PBS complementary
to tRNAMet(i) or tRNAMet(i)AG during replication and had
not reverted back to utilize the wild type tRNA as was the
case for HXB2-Met(e). Since the primer selected for repli-
cation was tRNAMet(i), we expected the PBS with the A to G
mutation would be converted back to complementarity
with tRNAMet(i) and consequently the virus would gradu-
ally loose infectivity during the culture. The growth of the
virus and the enrichment of viral genomes with the A to G
change in the PBS at later culture times suggest that the
viral genomes with the A to G change in the PBS were
favored for encapsidation.
Discussion
Although the process of tRNA primer selection required
for HIV-1 reverse transcription represents a critical step in
replication, it is as yet unresolved as to how the virus is
able to select tRNAs from the intracellular milieu that will
subsequently be used in replication. HIV-1 has the capac-
ity to utilize many different tRNA primers for replication,
since alteration of the PBS corresponding to numerous
Endogenous reverse transcription of wild type and mutant viruses Figure 5
Endogenous reverse transcription of wild type and mutant viruses. The endogenous reverse transcription assay was 
performed as described in the Materials and Methods. Autoradiography was used to identify radioactive areas, and the individ-
ual areas were excised and the radiation was quantitated using a scintillation counter. The values presented were then normal-
ized to the levels of virus as determined by p24 antigen ELISA. The total reaction time was for 60 minutes with samples being 
assayed at 1, 5, 15, 30 and 60 minutes. The order of the samples are HXB2-Met(i) (rectangles), HXB2-Met(e) (squares) and 
HXB2-WT (solid bars). Data is representative from three independent experiments.
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Analysis of HXB2-Met(i) with A to G mutation in PBS Figure 6
Analysis of HXB2-Met(i) with A to G mutation in PBS. Panel A. HXB2-Met(i) with A to G mutation. The PBS of 
HXB2-Met(i) with the ATG codon as boxed. A new mutant, HXB2-Met(i)AG was constructed in which the adenine was 
changed to guanine to eliminate the ATG (boxed). Panel B. Production of p24 following transfection. Proviral genome HXB2-
Met(i)AG was transfected into 293T cells and the amount of virus produced was determined using the p24 antigen ELISA assay. 
For comparison, the p24 values for HXB2-Met(e), HXB2-Met(i) and HXB2-WT are presented. Error bars ± standard devia-
tion. Panel C. Production of infectious virus following transfection of proviral genomes into 293T cells. The amount of infec-
tious virus is determined by the JC53-BL assay was determined for viruses derived from transfection of HXB2-Met(i)AG. For 
comparison, the amounts of infectious virus from HXB2-Met(e), HXB2-Met(i) and HXB2-WT are also presented. Error bars ± 
standard deviation.Panel D. Replication of HXB2-Met(i) with A to G mutation in SupT1 cells. The replication of HXB2-
Met(i)AG was analyzed in SupT1 cells. The amount of virus produced was determined by p24 antigen capture assay. Data is 
representative from two independent experiments. The samples are as marked in the figure.
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tRNAs results in replication competent viruses [15-17].
The capacity to select many different tRNAs for primer
selection suggests that this process mostly occurs at or
near the site of translation, where the virus would have
access to a variety of different tRNAs. To further explore a
relationship between primer selection and translation, we
wanted to determine if there were differences with respect
to replication for HIV-1 viruses in which the PBS was com-
plementary to tRNAMet(e) or tRNAMet(i). These tRNAs per-
form two different and distinct functions in the cell
[28,29]. Initiator tRNAs form a ternary complex with
eukaryotic initiation factor 2 (eIF2) and GTP, which exclu-
sively binds to the ribosomal P site and is excluded from
the ribosomal A site. In contrast, tRNAMet(e) forms a com-
plex with eEF1 and GTP and binds to the ribosomal A site
[28,29]. Thus, these two tRNAs interact with different pro-
teins and, quite possibly, are located within different
micro-environments within the cytoplasm of the cell. If
HIV-1 primer selection was co-ordinated with viral trans-
lation, we would expect that forcing the virus to use
(tRNAMet(i)) might impact on virus replication.
Transfection of HXB2-Met(e) and HXB2-WT produced
similar amounts of virus, as measured by p24 antigen.
Consistent with our previous results, HXB2-Met(e) was
replication competent and grew to levels similar to that of
wild type though, upon extended culture, these viruses
did revert back to use tRNALys,3 [20,22]. It is important to
note that the viruses used in this study did not contain the
additional mutations within the U5 that are known to sta-
bilize the virus to utilize tRNAMet(e) [20,22]. In contrast,
viruses in which the PBS was complementary to tRNAMet(i)
were infectious, but at a level that was greatly reduced
compared to HXB2-WT or HXB2-Met(e). Due to the low
infectivity, the virus did not productively infect SupT1
cells. Since to date, this is the only HIV-1 with a PBS com-
plementary to a mammalian tRNA that did not produc-
tively infect SupT1 cells, we further analyzed this virus to
determine the reason for this phenotype. Characterization
of this virus revealed that alteration of the PBS to be com-
plementary to tRNAMet(i) resulted in a reduction in the
overall amounts of virus (as measured by p24 antigen)
and infectivity (as measured by the JC53-BL assay). The
low infectivity of HXB2-Met(i) though was not due to
overall lower levels of tRNAMet(i) compared to tRNAMet(e)
in SupT1 cells. A previous study, also found that
tRNAMet(e) and tRNAMet(i) were present at similar levels in
replicating cells, similar to the conditions seen in the con-
tinuously replications SupT1 cultures [36]. We also found
that HIV-1 could select tRNAMet(i) for use as a primer.
Using an endogenous reverse transcription reaction, we
found the levels of incorporation (representing minus
strong stop DNA primed from the cognate tRNA) were
similar for HXB2-Met(e) and HXB2-Met(i) following nor-
malization to equal amounts of virus. The amount of
endogenous reaction product for both HXB2-Met(i) and
HXB2-Met(e) was less than that from HXB2-WT, consist-
ent with the effect that alteration of the PBS has on infec-
tivity. More importantly, the results demonstrate that
there is no inherent problem with tRNAMet(i) that pre-
cludes its use as a primer for reverse transcription. There
is, in fact, a precedence for tRNAMet(i) to be used as a
primer for reverse transcription. Ty1 retrotransposons of
yeast use tRNAMet(i) as the primer for transposition, which
has many similarities with reverse transcription [37].
Most probably the major reason for the low replication of
HXB2-Met(i) was the presence of an AUG in the 5' NTR
prior to the start of Gag. From on our analysis, the AUG in
the PBS of HXB2-Met(i) probably acted to syphon off
scanning ribosomes, thus reducing the efficiency for start
of Gag translation, resulting in the lower amount of virus
production (and inability to sustain virus infection).
Elimination of the AUG by the A to G mutation in the PBS
restored virus production (by p24) and increased infectiv-
ity to levels similar to HXB2-Met(e). Virus replication was
compromised though in SupT1 cells since tRNAMet(i) was
still selected as the primer. The fact that HXB2-Met(i)AG
replicated in SupT1 cells is consistent with our results that
tRNAMet(i) can be selected and used as the primer, albeit at
a lower efficiency than tRNALys,3.
An unexpected result from our study occurred from the
analysis of the PBS of HXB2-Met(i)AG following extended
replication in SupT1 cells. Following reverse transcription,
the PBS would be expected to contain fifty percent A to G
mutations, inherited from RT copying the plus-strand
RNA (generating minus-strand DNA), and fifty percent
PBS complementary to tRNAMet(i) plus-strand DNA inher-
ited from copying the tRNAMet(i) primer. Unless a bias
occurred during DNA repair, we would expect that from
each completion of reverse transcription, the PBS of pro-
viruses would contain equal numbers with and without
the A to G mutation. Since, the proviruses with the PBS
complementary to tRNAMet(i)  would be non-infectious
due to the AUG in the PBS, we would have expected that
as a result of the continued use of tRNAMet(i), the numbers
of repaired (A to G) PBS would be reduced following rep-
lication until no infectious virus was recovered. Surpris-
ingly, we found that after extended culture time, the
amount of virus increased, with the PBS containing the A
to G change, suggesting that an additional selection
occurred that favored the repaired genomes (A to G).
Conclusion
The results from our study suggest a link between primer
selection, encapsidation of genomic RNA and translation.
During translational elongation, microenvironments
within the cytoplasm are probably created to facilitate
translation. For example, a multi-component complex ofRetrovirology 2007, 4:10 http://www.retrovirology.com/content/4/1/10
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aminoacyl synthetases have been characterized, forming
what is referred to as a "nebula" of tRNA and host cell pro-
teins (aminoacyl-synthetases, eEF-1) that facilitate effi-
cient translation [38-40]. Possibly, HIV-1 primer selection
has evolved to select the tRNA primer from a pool of
tRNAs that are found in the micro-environment in the
cytoplasm that occurs during translation. A previous study
found that pseudovirions, composed of Gag and Gag-pol,
contain similar amounts of tRNALys,3 as the wild type
virus, but pseudovirions composed of Gag without Gag-
pol do not show enhanced tRNALys,3  incorporation
[41,42], suggesting that Gag-pol could be involved with
primer selection. It is also possible that the translation of
Gag-pol could facilitate primer selection. This process
could also be co-ordinated with the interaction of Gag
with the genomic RNA, which has been suggested as a sig-
nal for encapsidation [27,43-45]. Gag binding to the 5'
non-translated region of the HIV-1 genome would also
inhibit new translation. This process could be co-ordi-
nated, or facilitated by the tRNA interaction with the PBS
and targeting the genomic RNA for encapsidation. Target-
ing of genomic RNAs that are used in translation for
encapsidation would explain the capacity of HXB2-
Met(i)AG to amplify in culture even though tRNAMet(i)
was still selected as the primer for reverse transcription.
Additional studies will be required to test this possibility
and to further delineate the link between primer selection,
encapsidation and translation of genomic RNA.
Materials and methods
Tissue culture
The 293T and JC53BL cells were maintained in Dulbecco's
Modified Eagle's Medium (DMEM) (Cellgro by Medi-
atech, Inc.), L-glutamine, antibiotics and 10% fetal bovine
serum. The SupT1 cells were maintained in RPMI 1640, L-
glutamine, antibiotics and 15% FBS.
HIV-1 proviral mutants
The PBS of the provirus HXB2 was mutated to be compli-
mentary to the 3' end of the human tRNA elongator
methionine (tRNAMet(e)) to create (HXB2-Met(e))
[20,22,46]. To construct an HIV-1 with a PBS complemen-
tary to tRNAMet(i) as well as to tRNAMet(i) with an A to G
mutation at position 13 (tRNAMet(i)AG), the Quickchange
II Site Directed mutagenesis Kit (Stratagene) was used
with the following sets of primers:
5' ggaaaatctctagcagtggtagcagaggatggttctgaaagcgaaag-
ggaaac 3' Met(i)
5' gtttccctttcgctttcagaaccatcctctgctaccactgctagagattttcc 3'
5' ggaaaatctctagcagtggtagcagagggtggttctgaaagcgaaag-
ggaaac 3' Met(i) AG
5' gtttccctttcgctttcagaaccaccctctgctaccactgctagagattttcc 3'
and the transfer plasmid pUC119 HXB2 as previously
described (the underlined nucleotides correspond to the
mutation to create PBS complementary to tRNAMet(i) or
tRNAMet(i)AG, respectively. [20,22]. HpaI and BssHII (New
England Biolabs) were used to excise an 868 base pair
fragment from the transfer plasmid and HXB2-WT. The
products of the digestion reaction were run on a 1% agar-
ose gel. Fragments containing the PBS mutation as well as
the HXB2-WT backbone, were excised and gel purified
(Qiagen). Finally the fragments were ligated into the
HXB2-WT backbone. The resulting plasmids were named
HXB2-Met(i) and HXB2-Met(i)AG, respectively, and are
isogenic with HXB2 except for the PBS.
DNA transfections
Transfections were performed according to the protocol
for the Fugene 6 transfection reagent (Roche Molecular
Biochemicals). Briefly, proviral plasmid DNA and Fugene
reagent (varying amounts depending upon the experi-
ment) were added to 100 microliters of DMEM without
FBS. This mixture was incubated at room temperature for
approximately 45 minutes and added drop wise to one
well of a six well plate containing 60% of 293T cells and
DMEM and 10% FBS. The transfections were incubated
overnight at 37° and the medium was then replaced with
fresh DMEM containing 10% FBS. After 48 hours, all the
supernatants were collected, filtered and stored at -80°C.
The supernatants from the transfected cells were assayed
for HIV-1 p24 (Beckman Coulter) and the infectivity was
determined using the JC53-BL assay [33].
Analysis of virus replication
1 × 106 SupT1 cells were infected with equal amounts of
infectious virus (200IU) as measured by the JC53 reporter
assay. The infected SupT1 cells were monitored visually
for the formation of syntitia and cell counts were main-
tained at 1 × 106 cells/ml at time of passage either by
removing or adding additional cells. 1.5 ml of SupT1 cul-
tures were collected at various time points. The cultures
were spun down in a table-top centrifuge at 13000 × g for
1 minute. Supernatant was removed and analyzed for p24
antigen by ELISA (Coulter Laboratories).
PCR amplification and DNA sequencing of PBS-containing 
proviral DNA
Following the manufacturer's instructions, high molecu-
lar DNA was isolated from the cells that remained after
centrifugation of cultures and removal of supernatant
using a Wizard Genomic DNA Isolation Purification Kit
(Promega). Cellular DNA was used to amplify the U5 and
PBS regions of integrated proviral DNA sequences by
using the following HIV-1 proviral-DNA-specific primers:
5' cggaattctctccttctagcctccgctagt 3' and 5' ccttgacgatgcgatc-Retrovirology 2007, 4:10 http://www.retrovirology.com/content/4/1/10
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taccacacacaaggc 3'. PCR-amplified DNA was directly
ligated into the pGEM-T-easy vector (Promega). Follow-
ing transformation into E. coli and screening, the U5-PBS-
containing plasmid DNAs prepared from individual
recombinant clones were sequenced by using the primer
5' cggaattctctccttctagcctccgctagt 3'.
RNA isolation and analysis of tRNA
Tri Reagent™ (Sigma Chemicals) was used to extract total
cellular RNA from SupT1 cells as previously described
[46].  In vitro transcribed tRNA standards for tRNALys,3,
elongator methionine (tRNAMet(e)) and initiator methio-
nine (tRNAMet(i)), cDNA with T7 promoters upstream
were constructed via PCR of the following pairs of over-
lapping primers, respectively. Capital letters denote
sequence for T7 promoter:
1. 5'aattTAATACGACTCACTATAGGcccggatagctcagtcgg 3'
and 5'cgcccgaacagggacttgaaccctgg accctcagattaaaagtctgat-
gctctaccgactgagctatccgggc 3' (tRNALys,3);
2. 5' aattTAATACGACTCACTATAGGcctcgttagcgcagtagg 3'
and 5' tgccccgtgtgaggatcgaactcacg accttcagattatgagact-
gacgcgctacctactgcgctaacgagg 3 (tRNAMet(e));
3. 5' aattTAATACGACTCACTATAGGagcagagtggcgcagcgg
3' and 5' tagcagaggatggtttcgatccatcg acctctgggttatgggcccag-
cacgcttccgctgcgccactctgct 3 (tRNAMet(i));
The tRNAs were synthesized from the cDNA using the T7
– Megashortscript Transcription Kit (Ambion) and puri-
fied from agarose gel as previously described [47].
In order to determine the relative amounts of tRNA
present in SupT1 cells, total cellular tRNA and various
amounts of synthesized tRNA as standards were separated
by electrophoresis and blotted using NorthernMax™-Gly
Kit (Ambion) [47]. The 3' primers used in the synthesis of
the tRNA cDNA were kinased with [γ-32P] ATP and used as
probes and exposed to X-ray film as previously described
[47]. Radioactivity was quantitated by excising the prod-
uct and directly counting (Cherenkov). A plot of the
amount of the radioactivity versus amount of in vitro tran-
scribed tRNA was used to derive a standard curve to quan-
titate the tRNA amounts from SupT1 cells. All values
obtained for each tRNA were within the linear range of the
standard curve.
Endogenous reverse transcription reaction
Large scale transfections of 293T cells with HXB2-WT,
HXB2-Met(e) and HXB2-Met(i) with Fugene 6 were done
and supernatant was collected after 72 hours. Virus was
concentrated by ultracentrifugation at 27000 rpm over-
night by an SW28 rotor and the pellet was resuspended in
about 200 μl Tris pH 8.2. For the endogenous RT reaction,
Tris pH 8.0 (67 mM), DTT (67 mM), MgCl2 200 mM, KCL
(6.6 mM) Triton X-100 (0.1%) and EDTA (0.66 mM) with
0.5 mM, dATP, dCTP, dGTP (Amersham) were added with
50 μCi of [∝-32P]-dTTP. For each condition, 15 μl of resus-
pended viral pellet was placed in a well of a 96 well round-
bottom plate and 75 μl of reaction cocktail was added.
The RT reaction was carried out at 37°C for 1, 5, 15, 30,
60 minutes and stopped adding 50 μl 0.2 M Na4P2O7. The
samples were then transferred to a biodyne B membrane
N/Str PS 0.45 μm pore size (Nalge Nunc International).
Using a vacuum manifold, the samples were aspirated
through the membrane with 150 μl buffer (NaH2PO4,
dH2O pH 6.8) was passed through the membrane twice as
a wash. Further washing was accomplished by placing the
membrane into wash buffer and onto an orbital shaker for
10–15 minutes. The membrane was dried and exposed for
4 hours at -80°C. The individual wells were cut out and
radiation was quantitated using a scintillation counter.
SDS-Page and immunoblotting
10 μl of the pelleted virus was analyzed by SDS-polyacry-
lamide gel (12%) electrophoresis (SDS-PAGE). Following
SDS-PAGE, a Trans-Blot (Biorad) was used to transfer pro-
teins to NitroPure nitrocellulose membrane (Micron Sep-
arations, Westborough, Mass.). Membranes were blocked
in 2% fat free milk overnight. The membrane was washed
with TBS-Tween 20 for 30 minutes and then incubated
with the primary Rabbit anti HIV-1 p24 polyclonal anti-
body (NIH AIDS Repository, Catalog # 4250) suspended
in 2% milk for 60 minutes, washed several times with
TBS-Tween and incubated with mouse anti-rabbit Ab con-
jugated with horseradish peroxidase in 2% milk/TBS for
60 minutes. Following washing with several changes, the
blot was incubated in ECL detection reagent according to
the manufacture's directions (Amersham). Membranes
were then exposed to X-ray film and were scanned; the
intensity of the bands analyzed using ImageJ [48].
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